Literature DB >> 22692948

Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular Carcinoma.

Diana Katiman1, Jeeta Manikam1, Khean-Lee Goh1, Basri Johan Abdullah2, Sanjiv Mahadeva3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22692948     DOI： 10.1007/s12029-012-9373-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  14 in total

1.  Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma.

Authors:  Shannon G Lehner; Jennifer E Gould; Wael E A Saad; Daniel B Brown
Journal:  AJR Am J Roentgenol       Date:  2005-11       Impact factor: 3.959

2.  Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma.

Authors:  Chien-Chang Lee; Yuan-Huei Wu; Shen-Hung Chung; Wen-Jone Chen
Journal:  Oncologist       Date:  2006-01

3.  Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma.

Authors:  I A Burney
Journal:  South Med J       Date:  1998-05       Impact factor: 0.954

Review 4.  Tumor lysis syndrome in small cell carcinoma and other solid tumors.

Authors:  G P Kalemkerian; B Darwish; M L Varterasian
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

5.  Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma.

Authors:  Noriaki Sakamoto; Shuichi Monzawa; Hidenobu Nagano; Hogara Nishizaki; Yasuaki Arai; Kazuro Sugimura
Journal:  Cardiovasc Intervent Radiol       Date:  2007 May-Jun       Impact factor: 2.740

6.  Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.

Authors:  Boris Guiu; Frédéric Deschamps; Serge Aho; Flore Munck; Clarisse Dromain; Valérie Boige; David Malka; Sophie Leboulleux; Michel Ducreux; Martin Schlumberger; Eric Baudin; Thierry de Baere
Journal:  J Hepatol       Date:  2011-10-23       Impact factor: 25.083

Review 7.  Tumour lysis syndrome: new therapeutic strategies and classification.

Authors:  Mitchell S Cairo; Michael Bishop
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

8.  Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.

Authors:  Teh-Ia Huo; Jaw-Ching Wu; Pui-Ching Lee; Full-Young Chang; Shou-Dong Lee
Journal:  Liver Int       Date:  2004-06       Impact factor: 5.828

Review 9.  Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.

Authors:  Michael B Davidson; Snehal Thakkar; John K Hix; Naveen D Bhandarkar; Alan Wong; Martin J Schreiber
Journal:  Am J Med       Date:  2004-04-15       Impact factor: 4.965

10.  Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience.

Authors:  O Nawawi; Mn Hazman; Bjj Abdullah; A Vijayananthan; J Manikam; S Mahadeva; Kl Goh
Journal:  Biomed Imaging Interv J       Date:  2010-01-01
View more
  1 in total

1.  Successful treatment of acute tumor lysis syndrome associated with transcatheter chemoembolization with large hepatocellular carcinomas: two case reports.

Authors:  Hao Wang; Guang Chen; Haijun Gao; Zhengjia Yi
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.